Amanote Research
Register
Sign In
Rational Design of Polyphenol-Poloxamer Nanovesicles for Targeting Inflammatory Bowel Disease Therapy
doi 10.1021/acs.chemmater.8b01173.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Targeting Leukocyte Trafficking for the Treatment of Inflammatory Bowel Disease
Clinical Pharmacology and Therapeutics
Pharmacology
Author's Answer: Biosimilar Therapy for Inflammatory Bowel Disease
Revista Espanola de Enfermedades Digestivas
Medicine
Gastroenterology
Prostaglandins in Inflammatory Bowel Disease Therapy
Canadian Journal of Gastroenterology
Review: Anti-Adhesion Molecule Therapy for Inflammatory Bowel Disease
Therapeutic Advances in Gastroenterology
Gastroenterology
Rifaximin for Inflammatory Bowel Disease
Digestive Diseases and Sciences
Physiology
Gastroenterology
Inflammatory Bowel Disease
Annual Review of Immunology
Allergy
Immunology
Inflammatory Bowel Disease
American Journal of Gastroenterology
Hepatology
Gastroenterology
"Inflammatory" Bowel Disease.
BMJ
Inflammatory Bowel Disease
